Other
Peripheral Nerve Block
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Peripheral Nerve Block is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
21
clinical trials
Completed11 · 52%
Terminated4 · 19%
Unknown status3 · 14%
Enrolling by invitation1 · 5%
Not yet recruiting1 · 5%
Active, not recruiting1 · 5%
Clinical Trials
Trial Activity
21 trials
The Effect of a Prolonged Peripheral Nerve Block on the Level of Pain After a Knee Replacement
Not yet recruiting·—·N/A·NCT06382285·50 enrolled
Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery
Completed·—·Phase 4·NCT04311099·360 enrolled
Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair
Completed·—·Phase 4·NCT04737980·92 enrolled
Ultrasound Guided Distal Peripheral Nerve Blocks and Postoperative Pain.
Completed·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 4·NCT01597479·52 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)